Share on StockTwits

BioDelivery Sciences International (NASDAQ:BDSI) CFO Paolantonio Ernest Robert De bought 1,250 shares of the stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average price of $12.13 per share, with a total value of $15,162.50. Following the transaction, the chief financial officer now directly owns 2,250 shares in the company, valued at approximately $27,293. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on BDSI. Analysts at Ladenburg Thalmann raised their price target on shares of BioDelivery Sciences International to $18.00 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. Separately, analysts at Roth Capital raised their price target on shares of BioDelivery Sciences International to $15.50 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. Finally, analysts at Laidlaw reiterated a “buy” rating on shares of BioDelivery Sciences International in a research note on Monday, June 9th. They now have a $15.00 price target on the stock. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $19.25.

Shares of BioDelivery Sciences International (NASDAQ:BDSI) traded down 0.33% during mid-day trading on Friday, hitting $12.01. 1,141,735 shares of the company’s stock traded hands. BioDelivery Sciences International has a 52-week low of $4.05 and a 52-week high of $12.81. The stock has a 50-day moving average of $10.33 and a 200-day moving average of $8.39. The company’s market cap is $581.8 million. BioDelivery Sciences International also saw some unusual options trading on Friday. Stock investors purchased 11,691 call options on the stock. This is an increase of approximately 463% compared to the typical daily volume of 2,078 call options.

BioDelivery Sciences International (NASDAQ:BDSI) last issued its quarterly earnings data on Friday, May 9th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.04. The company had revenue of $20.69 million for the quarter, compared to the consensus estimate of $11.60 million. On average, analysts predict that BioDelivery Sciences International will post $-0.62 earnings per share for the current fiscal year.

BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.